Weight-bearing

Renowned NYC Foot Surgeon Dr. Stuart J. Mogul Introduces the Revolutionary Lapiplasty Mini-Incision™ Procedure for Accelerated Healing and Recovery

Retrieved on: 
Tuesday, April 9, 2024
ABC, Self (magazine), The New York Times, Weight-bearing, Patient, WebMD, Treace Medical Concepts, News, American College, Publication, Fox News, Position, Multimedia, ABC News, Dentistry

NEW YORK, April 9, 2024 /PRNewswire-PRWeb/ -- Dr. Stuart J. Mogul, a distinguished foot surgeon based in New York City, is proud to announce the incorporation of the groundbreaking Lapiplasty Mini-Incision™ Procedure into his practice. Developed by Treace Medical Concepts, this innovative surgical technique offers patients faster healing, quicker recovery times, and the ability to bear weight sooner following foot procedures.

Key Points: 
  • Patients requiring foot surgery have long relied on the expertise of esteemed New York Foot Surgeon, Dr. Stuart J.
  • Mogul, a distinguished foot surgeon based in New York City , is proud to announce the incorporation of the groundbreaking Lapiplasty Mini-Incision™ Procedure into his practice.
  • The Lapiplasty Mini-Incision™ Procedure revolutionizes foot surgery by addressing issues related to metatarsal alignment through a streamlined and highly effective approach.
  • Dr. Stuart Mogul is a diplomate of The American Board of Foot & Ankle Surgery and fellow of the American College of Foot and Ankle Surgeons.

Dror Paley, MD to Lead World's First Surgery with the PRECICE® Max System at Paley Orthopedic & Spine Institute

Retrieved on: 
Tuesday, February 20, 2024
PALM, Reconstruction, Weight-bearing, Globus Medical, Tibia, FDA, Femur, History, Health, NSO, Patient, Ageing, MAX, Birth control

WEST PALM BEACH, Fla,, Feb. 20, 2024 /PRNewswire-PRWeb/ -- Dr. Dror Paley, a globally renowned orthopedic surgeon and the Founder & CEO of the Paley Orthopedic & Spine Institute, is set to make medical history as he performs the first surgery in the world utilizing the PRECICE® Max System, developed by NuVasive Specialized Orthopedics™ (NSO), now a part of Globus Medical. This groundbreaking surgery marks a significant step forward in orthopedic innovation, emphasizing Dr. Paley's steadfast dedication to advancing the field and improving patient care. Furthermore, his selection as the inaugural surgeon further solidifies his reputation as the foremost authority in Limb Lengthening Deformity & Reconstruction Surgery worldwide.

Key Points: 
  • This groundbreaking surgery marks a significant step forward in orthopedic innovation, emphasizing Dr. Paley's steadfast dedication to advancing the field and improving patient care.
  • Furthermore, his selection as the inaugural surgeon further solidifies his reputation as the foremost authority in Limb Lengthening Deformity & Reconstruction Surgery worldwide.
  • Reflecting on the significance of this advancement, Dr. Paley stated, "I'm thrilled about the new Precice Max nail that I've contributed to developing.
  • As a global leader in orthopedic surgery, Dr. Paley's dedication to innovation and patient well-being shapes the future of orthopedic medicine.

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Retrieved on: 
Friday, February 2, 2024
HVA, Standard of care, Surgeon, IMA, American College, DPM, Trial of the century, Patient, Pain, TSP, Social, ACFAS, Bunion, Weight-bearing, Conference, Nursing

PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced three-year interim clinical data from its ALIGN3D™ post-market study supporting the use of the Lapiplasty® procedure for treating bunions were presented in a podium presentation at the 2024 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference .

Key Points: 
  • PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced three-year interim clinical data from its ALIGN3D™ post-market study supporting the use of the Lapiplasty® procedure for treating bunions were presented in a podium presentation at the 2024 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference .
  • “We believe these three-year clinical study results set a high standard for a commercial bunion technology and one that further differentiates Lapiplasty® in the marketplace with our surgeons and their patients.
  • The Company has submitted its primary endpoint ALIGN3D™ manuscript to a top-tier, peer-reviewed foot and ankle journal at the end of 2023 and expects publication in 2024.
  • More information on Treace’s products can be found at www.lapiplasty.com .

Paragon 28 Announces First Cases and Limited Market Release of the Bun-Yo-Matic™ – A Next Generation Clamp and Cut Guide System for Lapidus Bunion Procedures

Retrieved on: 
Wednesday, January 17, 2024
Surgery, Health, Medical Devices, Paragon, FNA, Multimedia, Foot, Clamp, Growth, Bunion, System, Weight-bearing, Surgeon, Anatomy, Medical imaging

Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its Bun-Yo-Matic™ Lapidus Clamp System and completion of the first surgical cases in Orange County, California and Seattle, Washington.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), is excited to announce the limited market release of its Bun-Yo-Matic™ Lapidus Clamp System and completion of the first surgical cases in Orange County, California and Seattle, Washington.
  • View the full release here: https://www.businesswire.com/news/home/20240117544407/en/
    Figure 1: Paragon 28 Bun-Yo-Matic™ Lapidus Clamp System (Graphic: Paragon 28)
    The Bun-Yo-Matic™ Clamp remains fixed to the anatomy throughout the entire procedure, ensuring surgeon-guided correction and anatomic alignment are maintained through application of fixation.
  • The Bun-Yo-Matic™ Clamp and accompanying cut guide system are highly complementary to Paragon 28’s broad line of bunion and forefoot solutions.
  • With this comprehensive portfolio, Paragon 28® provides its customers with a single source to address their bunion and forefoot needs.

Black Friday Bed Frame Deals 2023: Top Early Queen, King, Full, Twin, Double & More Bed Frame Deals Rated by Deal Stripe

Retrieved on: 
Thursday, November 2, 2023
Retail, Home Goods, Online, Taste, Stripe, Electronics, Black Friday, Weight-bearing, Walmart, Online shopping

Deal Stripe earns commissions from purchases made using the links provided.

Key Points: 
  • Deal Stripe earns commissions from purchases made using the links provided.
  • A bed frame is a crucial part of a bedroom, providing both support and aesthetic appeal.
  • When choosing a bed frame, consider the material, design, and size to complement a room's décor and ensure a comfortable sleeping environment.
  • As November 24 approaches, the anticipation builds, promising a day of unparalleled savings and unparalleled consumer enthusiasm.

CurvaFix Showcases Novel, Curved Intramedullary Devices for Pelvic Fixation at ACEP Scientific Assembly

Retrieved on: 
Thursday, October 5, 2023
Other Health, Research, Consumer, Medical Devices, Hospitals, Science, Surgery, Biotechnology, Seniors, FDA, Other Science, Health, BMI, FFP, Pain, Multimedia, Physician, ACEP, Foster, American College, Visual analogue scale, Pelvis, Weight-bearing, Mortality, Emergency, University, Patient, Bed rest, CT, Trauma, Emergency medicine, Medicine, Surgeon, Fellow of the American College of Emergency Physicians, VAS, Dentistry, Osteoporosis

CurvaFix, Inc ., a developer of medical devices to repair fractures in curved bones, announced today it will showcase the CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) at the American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, October 9-11, 2023, in booth #1935.

Key Points: 
  • CurvaFix, Inc ., a developer of medical devices to repair fractures in curved bones, announced today it will showcase the CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) at the American College of Emergency Physicians (ACEP) Scientific Assembly in Philadelphia, October 9-11, 2023, in booth #1935.
  • View the full release here: https://www.businesswire.com/news/home/20231005741542/en/
    The CurvaFix® IM Implants for geriatric fragility fractures of the pelvis (FFP) will be showcased at the American College of Emergency Physicians (ACEP) Scientific Assembly, Oct. 9-11 in booth #1935.
  • As such, we are pleased to make our debut at the ACEP Scientific Assembly, the world’s largest emergency medicine educational conference,” said Mark Foster , chief executive officer at CurvaFix.
  • “Emergency Medicine physicians are often the first point of care for patients who sustain geriatric pelvic fractures or fragility fractures of the pelvis.

Sparta Biomedical Celebrates Prestigious Recognition in MedTech and Significant Milestone

Retrieved on: 
Thursday, August 24, 2023
Patent, Osteoarthritis, Weight-bearing, Elective surgery, United States Patent and Trademark Office, Von Ormy, Texas, Patient, Sport, Jogging, Medtech, Medical device

MORRISVILLE, N.C., Aug. 24, 2023 /PRNewswire/ -- Sparta Biomedical Inc, a pioneering medical technology company specializing in redefining osteoarthritis treatment, proudly reflects on a momentous period marked by significant recognition and notable achievements.

Key Points: 
  • MORRISVILLE, N.C., Aug. 24, 2023 /PRNewswire/ -- Sparta Biomedical Inc, a pioneering medical technology company specializing in redefining osteoarthritis treatment, proudly reflects on a momentous period marked by significant recognition and notable achievements.
  • MedTech Innovator, a distinguished nonprofit accelerator and competition platform within the healthcare industry, identified Sparta Biomedical as an exceptional innovator in the realm of orthopedics.
  • Reflecting on this achievement, CEO Dushyanth Surakanti stated, "We were honored that Sparta was chosen for the 2023 MedTech Innovator cohort.
  • This recognition underscores our dedication to developing innovative solutions that empower patients to regain mobility and lead lives of fulfillment."

Global Smart Scale Market to Surpass USD 5.54 Billion By 2031| Growth Market Reports

Retrieved on: 
Tuesday, May 30, 2023
Online, Weight-bearing, Completeness, Key, Stainless steel, Health, Health facility, Distribution, Artificial intelligence, Study, Glass, Human, Retail, Online shopping, Dietary supplement, Growth, Forecast

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.

Key Points: 
  • The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics.
  • For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/4713
    On the basis of region, the global smart scale market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
  • Technological advancements such as Artificial Intelligence (AI) in smart scales are anticipated to create lucrative opportunities in the market.
  • The glass segment is expected to hold a significant market share as the glass-based smart scale offers a maximum weight-bearing capacity.

Askel Healthcare has appointed globally renowned orthopedic surgeons and sports medicine specialists to its new Clinical Advisory Board to drive change in the treatment of knee cartilage repair

Retrieved on: 
Wednesday, May 17, 2023
Sport, Weight-bearing, CAB, Olympic Games, Elective surgery, Cartilage, Mannerheimintie, ICRS, Rehabilitation, Leg, Axel (name), Cell, Knee, Medial knee injuries, MD, Principal, Sports medicine, Environment, EEST, Dentistry, Medical device, Nursing, Terveystalo

HELSINKI, May 17, 2023 /PRNewswire/ -- Askel Healthcare, a Finnish medical technology company offering a new method for the treatment of knee cartilage defects, has established a Clinical Advisory Board (CAB) representing globally renowned orthopedic surgeons and sports medicine specialists in knee cartilage repair.

Key Points: 
  • HELSINKI, May 17, 2023 /PRNewswire/ -- Askel Healthcare, a Finnish medical technology company offering a new method for the treatment of knee cartilage defects, has established a Clinical Advisory Board (CAB) representing globally renowned orthopedic surgeons and sports medicine specialists in knee cartilage repair.
  • In the first phase of commercialization, Askel Healthcare is targeting the U.S. cartilage repair market with the COPLA® implant.
  • Supported by the high-level Clinical Advisory Board, the company aims to become the global standard of surgical knee cartilage repair.
  • The Clinical Advisory Board consists of internationally recognized specialists in the treatment of cartilage damage.

Peer-Reviewed Publication Shows Superiority of Moximed’s MISHA™ Knee System

Retrieved on: 
Wednesday, March 1, 2023
Medical Devices, Health, Surgery, Health Technology, Clinical Trials, General Health, Knee, University, MD, ISA, Pain, IDE, OA, Sports medicine, Standard of care, FDA, Patient, Trial of the century, Weight-bearing, Surgeon, University of Virginia, Medical imaging, Cartilage

Moximed , a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the publication of a peer-reviewed article of the MISHA™ Knee System, an implantable shock absorber (ISA) for the knee.

Key Points: 
  • Moximed , a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the publication of a peer-reviewed article of the MISHA™ Knee System, an implantable shock absorber (ISA) for the knee.
  • The two-year pivotal IDE study results and superiority of the primary endpoint of the Calypso Study of the MISHA Knee System were published in Cartilage .1 In the study, the MISHA Knee System was superior to high tibial osteotomy (HTO) when evaluated against a two-year composite endpoint, demonstrating pain relief, functional improvement, and a positive safety profile in patients with medial knee OA.
  • High Responder Rates: 95.8% of patients treated with an ISA reported clinically meaningful pain relief at two years.
  • “The MISHA Knee System achieved its IDE study primary endpoint with superiority.